Which Institutions Own Shares In AIkido Pharma Inc. (AIKI)?

19 institutions hold shares in AIkido Pharma Inc. (AIKI), with 24k shares held by insiders accounting for 0.03% while institutional investors hold 8.56% of the company’s shares. The shares outstanding are 34.99M, and float is at 32.96M with Short Float at 1.64%. Institutions hold 8.55% of the Float.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 0.14 million shares valued at $0.13 million. The investor’s holdings represent 0.16% of the AIKI Shares outstanding. As of Dec 30, 2020, the second largest holder is Geode Capital Management, LLC with 0.14 million shares valued at $0.12 million to account for 0.16% of the shares outstanding. The other top investors are Virtu Financial LLC which holds 88326.0 shares representing 0.10% and valued at over $77152.0, while Citadel Advisors LLC holds 0.09% of the shares totaling 84445.0 with a market value of $73762.0.

AIkido Pharma Inc. (NASDAQ: AIKI) is 27.07% higher on its value in year-to-date trading and has touched a low of $0.47 and a high of $2.71 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AIKI stock was last observed hovering at around $1.14 in the last trading session, with the day’s loss setting it -0.03% off its average median price target of $1802.25 for the next 12 months. It is also 99.94% off the consensus price target high of $1802.25 offered by 0 analysts, but current levels are 99.94% higher than the price target low of $1802.25 for the same period.

Currently trading at $1.11, the stock is -9.24% and -19.67% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 13.42 million and changing -2.63% at the moment leaves the stock 22.32% off its SMA200. AIKI registered 81.00% gain for a year compared to 6-month gain of 84.97%. The firm has a 50-day simple moving average (SMA 50) of $1.2873 and a 200-day simple moving average (SMA200) of $0.9253.

The stock witnessed a 2.78% loss in the last 1 month and extending the period to 3 months gives it a 30.21%, and is -2.63% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.75% over the week and 9.82% over the month.

Distance from 52-week low is 138.40% and -59.04% from its 52-week high.

AIkido Pharma Inc. (AIKI) Analyst Forecasts

AIkido Pharma Inc. is expected to release its quarterly report on 08/17/2021 and quarterly earnings per share for the current quarter are estimated at $0 with sales reaching $6.5M over the same period.The EPS is expected to shrink by -282.90% this year

AIkido Pharma Inc. (AIKI) Insider Activity

A total of 0 insider transactions have happened at AIkido Pharma Inc. (AIKI) in the last six months, with sales accounting for 0 and purchases happening 0 times.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free